MAPT and myeloid sarcoma: Among different clinical MS characteristics, a lower total tau protein concentration was found in patients with sensory symptoms compared with the intact sensory system (83.75 pg/mL, IQR 60.80–149.79, and 180.83 pg/mL, IQR 135.83–234.63-, p = 0.033).